PTX 4.88% 3.9¢ prescient therapeutics limited

Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial, page-53

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,348 Posts.
    lightbulb Created with Sketch. 319
    it states that "an expected pCR of 16% with the current standard of care" and they achieved 27% of you include the woman who passed away, if not it would be around 20%... they where aiming to demonstrate three pCRs which they just about did, obviously I'm misinterpreting this info, happy to be corrected Doc ?
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.